Literature DB >> 17576019

Ubiquitination of MDM2 modulated by Epstein-Barr virus encoded latent membrane protein 1.

Lili Li1, Zijian Li, Shanghui Zhou, Lanbo Xiao, Lili Guo, Yongguang Tao, Min Tang, Ying Shi, Wei Li, Wei Yi, Ya Cao.   

Abstract

Epstein-Barr virus encoded latent membrane protein 1 (LMP1), an oncogenic protein, plays an important role in the carcinogenesis of nasopharyngeal carcinoma. The MDM2 gene is a cellular pro-oncogene that is abnormally up-regulated in human tumors. MDM2 is overexpressed in nasopharyngeal carcinoma, which is associated with the presence of EBV and cervical lymph node metastasis. Because MDM2 is capable of self-ubiquitination, and the ubiquitin proteasome pathway-dependent degradation is an important mechanism for regulating MDM2 levels in cells. Here we show that LMP1 augment MDM2 protein expression in dose-dependent level, and also lead to a drastic accumulation of ubiquitinated MDM2 species, this effect is associated with the stability of MDM2 modulated by LMP1. This is the first time to explain LMP1-regulated MDM2 through a post-ubiquitination mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576019     DOI: 10.1016/j.virusres.2007.05.013

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  9 in total

1.  Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.

Authors:  Chaofeng Tu; Zhaoyang Zeng; Peng Qi; Xiayu Li; Zhengyuan Yu; Can Guo; Fang Xiong; Bo Xiang; Ming Zhou; Zhaojian Gong; Qianjin Liao; Jianjun Yu; Yi He; Wenling Zhang; Xiaoling Li; Yong Li; Guiyuan Li; Wei Xiong
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

2.  TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1.

Authors:  Shunbin Ning; Alex D Campos; Bryant G Darnay; Gretchen L Bentz; Joseph S Pagano
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

3.  Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1/3 ubiquitination.

Authors:  Xiaolan Liu; Yueshuo Li; Songling Peng; Xinfang Yu; Wei Li; Feng Shi; Xiangjian Luo; Min Tang; Zheqiong Tan; A M Bode; Ya Cao
Journal:  Cell Death Dis       Date:  2018-01-19       Impact factor: 8.469

4.  Cadherin 6 is activated by Epstein-Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma.

Authors:  L-L Zuo; J Zhang; L-Z Liu; Q Zhou; S-J Du; S-Y Xin; Z-P Ning; J Yang; H-B Yu; W-X Yue; J Wang; F-X Zhu; G-Y Li; J-H Lu
Journal:  Oncogenesis       Date:  2017-12-22       Impact factor: 6.524

Review 5.  An update: Epstein-Barr virus and immune evasion via microRNA regulation.

Authors:  Lielian Zuo; Wenxin Yue; Shujuan Du; Shuyu Xin; Jing Zhang; Lingzhi Liu; Guiyuan Li; Jianhong Lu
Journal:  Virol Sin       Date:  2017-06-26       Impact factor: 4.327

6.  Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals.

Authors:  Xianlu Zhuo; Huiping Ye; Qi Li; Zhaolan Xiang; Xueyuan Zhang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 7.  LncRNAs regulate cancer metastasis via binding to functional proteins.

Authors:  Liting Yang; Yanyan Tang; Fang Xiong; Yi He; Fang Wei; Shanshan Zhang; Can Guo; Bo Xiang; Ming Zhou; Ni Xie; Xiaoling Li; Yong Li; Guiyuan Li; Wei Xiong; Zhaoyang Zeng
Journal:  Oncotarget       Date:  2017-12-01

Review 8.  Extracellular vesicles: novel vehicles in herpesvirus infection.

Authors:  Lingzhi Liu; Quan Zhou; Yan Xie; Lielian Zuo; Fanxiu Zhu; Jianhong Lu
Journal:  Virol Sin       Date:  2017-10-30       Impact factor: 4.327

Review 9.  Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer.

Authors:  Ramon Yarza; Mateo Bover; Maria Teresa Agulló-Ortuño; Lara Carmen Iglesias-Docampo
Journal:  J Exp Clin Cancer Res       Date:  2021-06-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.